Femke Hooijberg

Research output

Research output per year 2019 2021 2022 2023 2024

• 9 Article
• 6 Comment/Letter to the editor

Research output per year

Research output per year

Search results

• 2024

  Therapeutic drug monitoring countering the effect of anti-infliximab antibodies

  Hooijberg, F. & Wolbink, G., 1 Apr 2024, In: The Lancet Rheumatology. 6, 4, p. e193-e194

  Research output: Contribution to journal › Comment/Letter to the editor › Academic
• 2023

  Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated

  Raadsen, R., Hansildaar, R., Pouw, L. C., Hooijberg, F., Boekel, L., Wolbink, G. J., van Kuijk, A. W. R. & Nurmohamed, M. T., 1 Dec 2023, In: RMD OPEN. 9, 4, e003485.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  1 Citation (Scopus)

• Formation and clearance of TNF–TNF inhibitor complexes during TNF inhibitor treatment

  Berkhout, L. C., I'Ami, M. J., Kruithof, S., Vogelzang, E. H., Hooijberg, F., Hart, M. H. L., Bentlage, A. E. H., Thomas, D., Vermeire, S., Vidarsson, G., ten Brinke, A., Nurmohamed, M. T., Wolbink, G. J. & Rispens, T., 2023, (E-pub ahead of print) In: British journal of pharmacology.

  Research output: Contribution to journal › Article › Academic › peer-review

• Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands

  Boekel, L., Atiqi, S., Leeuw, M., Hooijberg, F., Besten, Y. R., Wartena, R., Steenhuis, M., Vogelzang, E., Webers, C., Boonen, A., Gerritsen, M., Lems, W. F., Tas, S. W., van Vollenhoven, R. F., Voskuyl, A. E., van der Horst-Bruinsma, I., Nurmohamed, M., Rispens, T. & Wolbink, G., 1 Jul 2023, In: The Lancet Rheumatology. 5, 7, p. e375-e385

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  5 Citations (Scopus)
• 2022

  Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

  Boekel, L., Hooijberg, F., Vogelzang, E. H., Besten, Y. R., Leeuw, M., Atiqi, S., van Vollenhoven, R. F., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Dijkshoorn, B., Bakhlakh, S., Crooijmans, J. J., Voskuyl, A., van der Horst-Bruinsma, I. E., Lems, W., Kuijpers, T. W., van Ham, S. M., Wieske, L., Eftimov, F., & 13 othersKummer, L. Y., van Dam, P. K., Stalman, E. W., Steenhuis, M., Keijzer, S., Cristianawati, O., Keijser, J., Loeff, F. C., Tas, S. W., Nurmohamed, M. T., Boers, M., Rispens, T. & Wolbink, G., 5 Apr 2022, In: RMD OPEN. 8, 1, 002035.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  12 Citations (Scopus)

• Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies

  T2B! immunity against SARS-CoV-2 study group, 1 Jun 2022, In: The Lancet Rheumatology. 4, 6, p. e417-e429

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  34 Citations (Scopus)

• COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases

  Boekel, L., Hooijberg, F., Besten, Y. R., Vogelzang, E. H., Steenhuis, M., Leeuw, M., Atiqi, S., van Vollenhoven, R., Lems, W. F., Bos, W. H., Wijbrandts, C. A., Gerritsen, M., Krieckaert, C., Voskuyl, A. E., van der Horst-Bruinsma, I. E., Tas, S. W., Boers, M., Rispens, T., Nurmohamed, M. T. & Wolbink, G., 1 May 2022, In: The Lancet Rheumatology. 4, 5, p. e310-e313

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  12 Citations (Scopus)

• EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases

  Krieckaert, C. L. M., van Tubergen, A., Gehin, J. E., Hernández-Breijo, B., le Mélédo, G., Balsa, A., Böhm, P., Cucnik, S., Elkayam, O., Goll, G. L., Hooijberg, F., Jani, M., Kiely, P. D. W., McCarthy, N., Mulleman, D., Navarro-Compán, V., Payne, K., Perry, M. E., Plasencia-Rodriguez, C., Stones, S. R., & 5 othersSyversen, S. W., de Vries, A., Ward, K. M., Wolbink, G. & Isaacs, J. D., 12 May 2022, In: Annals of the rheumatic diseases. 82, 1, p. 65-73 9 p.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  22 Citations (Scopus)

• Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial

  Ruwaard, J., l’ Ami, M. J., Kneepkens, E. L., Krieckaert, C. L. M., Nurmohamed, M. T., Hooijberg, F., van Kuijk, A. W. R., van Denderen, J. C., Burgemeister, L., Rispens, T., Boers, M. & Wolbink, G. J., 2022, (E-pub ahead of print) In: Scandinavian Journal of Rheumatology.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  8 Citations (Scopus)

• SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period

  Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., Rispens, T., & 3 othersBoers, M., Nurmohamed, M. T. & Wolbink, G., 1 Nov 2022, In: The Lancet Rheumatology. 4, 11, p. e747-e750 4 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  8 Citations (Scopus)
• 2021

  Adverse events after first COVID-19 vaccination in patients with autoimmune diseases

  Boekel, L., Kummer, L. Y., van Dam, K. P. J., Hooijberg, F., van Kempen, Z., Vogelzang, E. H., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., Killestein, J., Boers, M., Nurmohamed, M. T., Rispens, T. & Wolbink, G., 1 Aug 2021, In: The Lancet Rheumatology. 3, 8, p. e542-e545

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  58 Citations (Scopus)

• Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies

  Boekel, L., Steenhuis, M., Hooijberg, F., Besten, Y. R., van Kempen, Z. L. E., Kummer, L. Y., van Dam, K. P. J., Stalman, E. W., Vogelzang, E. H., Cristianawati, O., Keijzer, S., Vidarsson, G., Voskuyl, A. E., Wieske, L., Eftimov, F., van Vollenhoven, R., Kuijpers, T. W., van Ham, S. M., Tas, S. W., Killestein, J., & 4 othersBoers, M., Nurmohamed, M. T., Rispens, T. & Wolbink, G., 1 Nov 2021, In: The Lancet. Rheumatology. 3, 11, p. e778-e788

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  120 Citations (Scopus)

• Perspective of patients with autoimmune diseases on COVID-19 vaccination

  Boekel, L., Hooijberg, F., van Kempen, Z. L. E., Vogelzang, E. H., Tas, S. W., Killestein, J., Nurmohamed, M. T., Boers, M., Kuijpers, T. W., van Ham, S. M., Eftimov, F., Wieske, L., Rispens, T. & Wolbink, G. J., 1 Apr 2021, In: The Lancet Rheumatology. 3, 4, p. e241-e243

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  68 Citations (Scopus)
• 2020

  Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population

  Hooijberg, F., Boekel, L., Vogelzang, E. H., Leeuw, M., Boers, M., van Vollenhoven, R., Lems, W. F., Nurmohamed, M. T. & Wolbink, G., Oct 2020, In: The Lancet Rheumatology. 2, 10, p. e583-e585

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  43 Citations (Scopus)
• 2019

  Creatine kinase and blood pressure in women with a history of early-onset preeclampsia

  Horjus, D. L., Bokslag, A., Hooijberg, F., Hutten, B. A., Middeldorp, S. & de Groot, C. J. M., 1 Jan 2019, In: Pregnancy Hypertension. 15, p. 118-122 5 p.

  Research output: Contribution to journal › Article › Academic › peer-review
  1 Citation (Scopus)